NUTRIRIC
Impact of Ultra-processed Foods in a Population of Patients With Chronic Rheumatic Diseases (Rheumatoid Arthritis, Spondyloarthritis, Osteoarthritis).
Sponsor study identifier
Secondary identifiers
OTHER · ID-RCB
observational
240
1 country
1
Study Start
March 31, 2025
Actual (reported)Primary Completion
March 31, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
November 30, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Ultra-processed foods (UPF) represent one of the mainstays of today's diet. They are defined by the NOVA classification system. It was demonstrated that UPF consumption was associated with activity of inflammatory bowel diseases with underlying mechanisms not fully identified yet. It is suspected that UPF constituents could modify the gut microbiota, increase intestinal barrier permeability and directly engage immune surveillance systems, effects that could individually or synergistically increase the risk of immunomediated diseases. As some pathophysiological mechanisms are shared among IBD and rheumatic diseases, we have wondered if UPF consumption could be associated with increased risk of rheumatic disease and/or with their activity. Our primary aim will be to study the pattern of UPF consumption in patients with rheumatic diseases. Our secondary objectives will be to study the activity of diseases according to UPF consumption.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 30, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 10, 2025
Actual (reported)January 15, 2025
Actual (reported)March 31, 2025
Actual (reported)March 31, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
November 30, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Describe the consumption of ultra-processed foods in patients with chronic inflammatory rheumatism
Describes the consumption of ultra-processed foods in patients with chronic inflammatory rheumatism using a self-assessment questionnaire (Score UPF Nova Screener) completed at baseline, 6 and 12 months.
At baseline
Patients in the first group will correspond to those with rheumatoid arthritis according to ACR criteria of RA
Patients in the second group will correspond to those with spondyloarthritis according ASDAS criteria
Patients in the third group will correspond to those with spondyloarthritis according ACR criteria
Self administered dietary questionnaire at baseline, 6 and 12 months.
Patients with chronic rheumatological diseases (spondylitis, rheumatoid arthritis, osteoarthritis) and control population (also followed for any other pathology in the department).
Edouard Herriot Hospital
Lyon, 69003, France
Maxime AUROUX, MD
Hôpital Edouard Herriot
First Submitted
January 10, 2025
First Posted
January 15, 2025
Study Start
March 31, 2025
Actual (reported)Primary Completion
March 31, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Biotherapies and Therapeutic Education in Chronic Inflammatory Rheumatism
Patients without rheumatic disease
Self administered questionnaire of disease activity at baseline, 6 and 12 months.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Study Completion
November 30, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
April 11, 2025
Record last verified: 2025-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: